BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22044798)

  • 1. Structure-activity relationship of sphingomyelin analogs with sphingomyelinase from Bacillus cereus.
    Sergelius C; Niinivehmas S; Maula T; Kurita M; Yamaguchi S; Yamamoto T; Katsumura S; Pentikäinen OT; Slotte JP
    Biochim Biophys Acta; 2012 Mar; 1818(3):474-80. PubMed ID: 22044798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of asp126 and asp156 in the enzyme function of sphingomyelinase from Bacillus cereus.
    Fujii S; Ogata K; Inoue B; Inoue S; Murakami M; Iwama S; Katsumura S; Tomita M; Tamura H; Tsukamoto K; Ikezawa H; Ikeda K
    J Biochem; 1999 Jul; 126(1):90-7. PubMed ID: 10393325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mg2+ binding and catalytic function of sphingomyelinase from Bacillus cereus.
    Fujii S; Inoue B; Yamamoto H; Ogata K; Shinki T; Inoue S; Tomita M; Tamura H; Tsukamoto K; Ikezawa H; Ikeda K
    J Biochem; 1998 Dec; 124(6):1178-87. PubMed ID: 9832623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premicellar complexes of sphingomyelinase mediate enzyme exchange for the stationary phase turnover.
    Yu BZ; Polenova T; Jain MK; Berg OG
    Biochim Biophys Acta; 2005 Jun; 1712(2):137-51. PubMed ID: 15878423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processive interfacial catalytic turnover by Bacillus cereus sphingomyelinase on sphingomyelin vesicles.
    Yu BZ; Zakim D; Jain MK
    Biochim Biophys Acta; 2002 Jun; 1583(1):122-32. PubMed ID: 12069857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis.
    Oda M; Imagawa H; Kato R; Yabiku K; Yoshikawa T; Takemoto T; Takahashi H; Yamamoto H; Nishizawa M; Sakurai J; Nagahama M
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):303-10. PubMed ID: 23488740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of side-edge site of sphingomyelinase from Bacillus cereus.
    Oda M; Takahashi M; Tsuge H; Nagahama M; Sakurai J
    Biochem Biophys Res Commun; 2012 May; 422(1):128-32. PubMed ID: 22564743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus cereus sphingomyelinase recognizes ganglioside GM3.
    Oda M; Fujita A; Okui K; Miyamoto K; Shibutani M; Takagishi T; Nagahama M
    Biochem Biophys Res Commun; 2013 Feb; 431(2):164-8. PubMed ID: 23313504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2NH and 3OH are crucial structural requirements in sphingomyelin for sticholysin II binding and pore formation in bilayer membranes.
    Maula T; Isaksson YJ; García-Linares S; Niinivehmas S; Pentikäinen OT; Kurita M; Yamaguchi S; Yamamoto T; Katsumura S; Gavilanes JG; Martínez-del-Pozo A; Slotte JP
    Biochim Biophys Acta; 2013 May; 1828(5):1390-5. PubMed ID: 23376330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus.
    Ago H; Oda M; Takahashi M; Tsuge H; Ochi S; Katunuma N; Miyano M; Sakurai J
    J Biol Chem; 2006 Jun; 281(23):16157-67. PubMed ID: 16595670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in aspartic acid residues modifies catalytic and haemolytic activities of Bacillus cereus sphingomyelinase.
    Tamura H; Tameishi K; Yamada A; Tomita M; Matsuo Y; Nishikawa K; Ikezawa H
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):757-64. PubMed ID: 7639690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and function of sphingomyelinase].
    Oda M
    Yakugaku Zasshi; 2009 Oct; 129(10):1233-8. PubMed ID: 19797879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shape transitions and lattice structuring of ceramide-enriched domains generated by sphingomyelinase in lipid monolayers.
    Härtel S; Fanani ML; Maggio B
    Biophys J; 2005 Jan; 88(1):287-304. PubMed ID: 15489298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibition mechanism of Bacillus cereus sphingomyelinase by beryllium fluoride.
    Fujii S; Nagata M; Morita M; Minoura K; Tsukamoto K; Ikezawa H; Ikeda K
    Arch Biochem Biophys; 2004 Apr; 424(2):201-9. PubMed ID: 15047192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid bilayers containing sphingomyelins and ceramides of varying N-acyl lengths: a glimpse into sphingolipid complexity.
    Jiménez-Rojo N; García-Arribas AB; Sot J; Alonso A; Goñi FM
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):456-64. PubMed ID: 24144542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glu-53 of Bacillus cereus sphingomyelinase acts as an indispensable ligand of Mg2+ essential for catalytic activity.
    Obama T; Kan Y; Ikezawa H; Imagawa M; Tsukamoto K
    J Biochem; 2003 Mar; 133(3):279-86. PubMed ID: 12761162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. His151 and His296 are the acid-base catalytic residues of Bacillus cereus sphingomyelinase in sphingomyelin hydrolysis.
    Obama T; Fujii S; Ikezawa H; Ikeda K; Imagawa M; Tsukamoto K
    Biol Pharm Bull; 2003 Jul; 26(7):920-6. PubMed ID: 12843611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfacial regulation of bacterial sphingomyelinase activity.
    Jungner M; Ohvo H; Slotte JP
    Biochim Biophys Acta; 1997 Feb; 1344(3):230-40. PubMed ID: 9059513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N- and O-methylation of sphingomyelin markedly affects its membrane properties and interactions with cholesterol.
    Björkbom A; Róg T; Kankaanpää P; Lindroos D; Kaszuba K; Kurita M; Yamaguchi S; Yamamoto T; Jaikishan S; Paavolainen L; Päivärinne J; Nyholm TK; Katsumura S; Vattulainen I; Slotte JP
    Biochim Biophys Acta; 2011 Apr; 1808(4):1179-86. PubMed ID: 21262197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor.
    Hakogi T; Taichi M; Katsumura S
    Org Lett; 2003 Aug; 5(16):2801-4. PubMed ID: 12889878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.